Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
FARMINGTON HILLS, Mich., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the...
-
Merger completed with Rexahn Pharmaceuticals creating a Nasdaq-listed Biopharmaceutical Company Focused on Advancing Ocuphire’s Late-Stage Clinical Pipeline of Ophthalmic Drug Candidates Trading...
-
FARMINGTON HILLS, Mich., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Ocuphire Pharma, a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the...
-
FARMINGTON HILLS, Mich., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc., a privately-held clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing...